Skip to main content

Table 9 Adherence to therapy in premenopausal breast cancer patients treated with tamoxifen or toremifene

From: A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

 

Tamoxifen (n = 240)

Toremifene (n = 212)

p value

 Total

45

31

0.242

 Transfer to AIs after menopause

24

15

0.269

 Discontinuance or other therapy

21

16

0.542

 Cervical cyst

1

0

 

 Uterine fibroids

1

0

 

 Ostalgia

1

0

 

 Skinrash

2

0

 

 Endometrial hyperplasia

5

0

 

 In order to be pregnancy

1

1

 

 Diarrhea

1

0

 

 To fear adverse effect

1

4

 

 Economic reason

1

0

 

 Transaminase step-up

1

2

 

 Chinese traditional medicine

2

0

 

 Discontinuance for unknow reasons

4

6

 

 Hyper-menorrhea

0

2

 

 Vaginal bleeding

0

1

Â